文献速递间质性肺疾病

致病突变体研究揭示表面活性蛋白C转运新机制

Novel insights into surfactant protein C trafficking revealed through the study of a pathogenic mutant.
PubMed 文献 · Eur Respir J · 2022-01-27

该研究通过细胞模型和人类原代肺泡类器官,机制性分析表面活性蛋白C(SFTPC)在健康与疾病状态下的转运。发现野生型SFTPC经质膜间接转运并发生切割后进入多囊体,而I73T突变体因转运受阻和主动再循环而蓄积于细胞表面。这首次揭示所有SFTPC在正常转运中均经过细胞表面,I73T突变通过转运延迟和再循环导致质膜蓄积,为IPF发病机制提供新见解。

要点

  • 野生型SFTPC正常转运经质膜间接路线并发生切割后进入多囊体。
  • I73T突变体转运在细胞表面和多囊体进入处均受阻。
  • I73T突变体以部分切割中间体形式再循环至质膜蓄积。

核心结论

  • 所有SFTPC在正常转运中均经过细胞表面。
  • I73T突变通过转运延迟和主动再循环导致质膜蓄积。
  • 该机制为SFTPC突变贡献IPF发展提供新见解。

研究设计与样本

  • 在重现体内表型的细胞模型中进行SFTPC转运机制分析。
  • 在人类原代肺泡类器官中验证发现。

主要发现

  • 野生型SFTPC经质膜间接转运,在到达多囊体前发生首次切割。
  • SFTPC-I73T沿相同路线但转运在细胞表面和多囊体进入处均受阻。
  • I73T突变体以部分切割中间体形式再循环至质膜。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

BACKGROUND: Alveolar epithelial cell dysfunction plays an important role in the pathogenesis of idiopathic pulmonary fibrosis (IPF), but remains incompletely understood. Some monogenic forms of pulmonary fibrosis are associated with expression of mutant surfactant protein C (SFTPC). The commonest pathogenic mutant, I73T, mislocalises to the alveolar epithelial cell plasma membrane and displays a toxic gain of function. Because the mechanisms explaining the link between this mutant and IPF are incompletely understood, we sought to interrogate SFTPC trafficking in health and disease to understand the functional significance of SFTPC-I73T relocalisation. METHODS: We performed mechanistic analysis of SFTPC trafficking in a cell model that reproduces the in vivo phenotype and validated findings in human primary alveolar organoids. RESULTS: We show that wild-type SFTPC takes an unexpected indirect trafficking route via the plasma membrane and undergoes the first of multiple cleavage events before reaching the multivesicular body (MVB) for further processing. SFTPC-I73T takes this same route, but its progress is retarded both at the cell surface and due to failure of trafficking into the MVB. Unable to undergo onward trafficking, it is recycled to the plasma membrane as a partially cleaved intermediate. CONCLUSION: These data show for the first time that all SFTPC transits the cell surface during normal trafficking, and the I73T mutation accumulates at the cell surface through both retarded trafficking and active recycling. This understanding of normal SFTPC trafficking and how the I73T mutant disturbs it provides novel insight into SFTPC biology in health and disease, and in the contribution of the SFTPC mutant to IPF development.

来源:Eur Respir J,查看原文。版权归原作者所有。

引用

  1. Dickens JA, Rutherford EN, Abreu S, et al. Novel insights into surfactant protein C trafficking revealed through the study of a pathogenic mutant. Eur Respir J. 2022. PMID: 34049951. doi:10.1183/13993003.00267-2021

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。